Abstract
A total of 773 pneumococcal isolates were collected from a nationwide surveillance of invasive pneumococcal diseases during 1999–2003 prior to the implementation of the 7-valent conjugate vaccine (PCV7) in Italy. The isolates included vaccine serotypes (VS, 393 isolates), vaccine-related serotypes (VRS, 93), and nonvaccine serotypes (NVS, 279). The ten most prevalent serotypes were: 14 (16.4%), 3 (8.4%), 23F (8%), 19F (7.4%), 4 (5.9%), 7F (5.8%), 9V (5.3%), 6B (4.9%), 19A (4.7%), and 1 (3.7%). VRS or NVS isolates showed a lower rate of penicillin or drug resistance than VS. Representative isolates of the major VS, VRS, and NVS were genotyped by pulsed field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). The isolates examined were found to belong to 18 international clones and to eight newly described clones. VS isolates sharing clonal groups with VRS or NVS were also detected. Evidence of a past history of capsular switching events was observed in five clones.
Abbreviations
- PCV7:
-
7-valent pneumococcal conjugate vaccine
- VS:
-
Vaccine serotypes
- VRS:
-
Vaccine-related serotypes
- NVS:
-
Nonvaccine serotypes
- IPD:
-
Invasive pneumococcal diseases
- PFGE:
-
Pulsed field gel electrophoresis
- PNSSP:
-
Penicillin-nonsusceptible Streptococcus pneumoniae
- DR-PSSP:
-
Drug-resistant penicillin-susceptible Streptococcus pneumoniae
- DSSP:
-
Drug-susceptible Streptococcus pneumoniae
- MLST:
-
Multilocus sequence typing
- ST:
-
Sequence type
- PMEN:
-
Pneumococcal Molecular Epidemiology Network
References
Obaro SK, Monteil MA, Henderson DC (1996) Fortnightly review: the pneumococcal problem. Br Med J 312:1521–1525
Hausdorff WP, Bryant J, Paradiso PR, Siber GR (2000) Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 30:100–121 doi:10.1086/313608
Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A; Active Bacterial Core Surveillance of the Emerging Infections Program Network (2003) Decline in invasive pneumococcal disease after the introduction of protein–polysaccharide conjugate vaccine. N Engl J Med 348:1737–1746 doi:10.1056/NEJMoa022823
Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, Thomas AR, Harrison LH, Bennett NM, Farley MM, Facklam RR, Jorgensen J, Besser J, Zell ER, Schuchat A, Whitney CG; Active Bacterial Core Surveillance of the Emerging Infections Program Network (2006) Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 354:1455–1463 doi:10.1056/NEJMoa051642
Barricarte A, Castilla J, Gil-Setas A, Torroba L, Navarro-Alonso JA, Irisarri F, Arriazu M (2007) Effectiveness of the 7-valent pneumococcal conjugate vaccine: a population-based case–control study. Clin Infect Dis 44:1436–1441 doi:10.1086/516779
Beall B, McEllistrem MC, Gertz RE Jr, Wedel S, Boxrud DJ, Gonzalez AL, Medina M-J, Pai R, Thompson TA, Harrison LH, McGee L, Whitney CG; Active Bacterial Core Surveillance Team (2006) Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002. J Clin Microbiol 44:999–1017 doi:10.1128/JCM.44.3.999-1017.2006
Brueggemann AB, Pai R, Crook DW, Beall B (2007) Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathol 3:e168 doi:10.1371/journal.ppat.0030168
Pantosti A, Boccia D, D’Ambrosio F, Recchia S, Orefici G, Moro ML; The National Surveillance of Bacterial Meningitis; The EARSS-Italia groups (2003) Inferring the potential success of pneumococcal vaccination in Italy: serotypes and antibiotic resistance of Streptococcus pneumoniae isolates from invasive diseases. Microb Drug Resist 9:S61–S68 doi:10.1089/107662903322541919
Gherardi G, Fallico L, Del Grosso M, Bonanni F, D’Ambrosio F, Manganelli R, Palù G, Dicuonzo G, Pantosti A (2007) Antibiotic-resistant invasive pneumococcal clones in Italy. J Clin Microbiol 45:306–312 doi:10.1128/JCM.01229-06
Dicuonzo G, Gherardi G, Gertz RE, D’Ambrosio F, Goglio A, Lorino G, Recchia S, Pantosti A, Beall B (2002) Genotypes of invasive pneumococcal isolates recently recovered from Italian patients. J Clin Microbiol 40:3660–3665 doi:10.1128/JCM.40.10.3660-3665.2002
Clinical and Laboratory Standards Institute (CLSI) (2006) Performance standards for antimicrobial susceptibility testing; 16th international supplement. CLSI, Wayne, PA
Monaco M, Camilli R, D’Ambrosio F, Del Grosso M, Pantosti A (2005) Evolution of erythromycin resistance in Streptococcus pneumoniae in Italy. J Antimicrob Chemother 55:256–259 doi:10.1093/jac/dkh551
Camilli R, Pettini E, Del Grosso M, Pozzi G, Pantosti A, Oggioni MR (2006) Zinc metalloproteinase genes in clinical isolates of Streptococcus pneumoniae: association of the full array with a clonal cluster comprising serotypes 8 and 11A. Microbiology 152:313–321 doi:10.1099/mic.0.28417-0
Porat N, Arguedas A, Spratt BG, Trefler R, Brilla E, Loaiza C, Godoy D, Bilek N, Dagan R (2004) Emergence of penicillin-nonsusceptible Streptococcus pneumoniae clones expressing serotypes not present in the antipneumococcal conjugate vaccine. J Infect Dis 190:2154–2161 doi:10.1086/425908
Sjöström K, Spindler C, Ortqvist A, Kalin M, Sandgren A, Kühlmann-Berenzon S, Henriques-Normark B (2006) Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen. Clin Infect Dis 42:451–459 doi:10.1086/499242
Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, Jackson D, Thomas A, Beall B, Lynfield R, Reingold A, Farley MM, Whitney CG (2007) Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998–2004. J Infect Dis 196:1346–1354 doi:10.1086/521626
Acknowledgments
The authors wish to thank all the collaborators of the surveillance studies who have provided Streptococcus pneumoniae isolates.
This study was supported in part by a grant from the Italian Ministry of Health, CCM project “Laboratory-based surveillance of infections due to antibiotic-resistant bacteria.”
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gherardi, G., D’Ambrosio, F., Monaco, M. et al. Population structure of invasive Streptococcus pneumoniae isolates in Italy prior to the implementation of the 7-valent conjugate vaccine (1999–2003). Eur J Clin Microbiol Infect Dis 28, 99–103 (2009). https://doi.org/10.1007/s10096-008-0581-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-008-0581-8